The Digestive System in the Era of COVID-19
In the last few years, the scientific world has been forced to find ways to manage the SARS-CoV-2 pandemic and its many effects. Even though COVID-19 was first considered a respiratory disease, it is now identified as a systematic disease. It is common for SARS-CoV-2 to also infect the digestive sys...
Na minha lista:
| Formato: | Online |
|---|---|
| Idioma: | inglês |
| Publicado em: |
MDPI - Multidisciplinary Digital Publishing Institute
2024
|
| Assuntos: | |
| Acesso em linha: | ONIX_20240514_9783725805716_365 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
| _version_ | 1869530179445981184 |
|---|---|
| collection | Directory of Open Access Books |
| description | In the last few years, the scientific world has been forced to find ways to manage the SARS-CoV-2 pandemic and its many effects. Even though COVID-19 was first considered a respiratory disease, it is now identified as a systematic disease. It is common for SARS-CoV-2 to also infect the digestive system. This type of infection in patients with COVID-19 has a wide symptom range. The aim of this reprint is to evaluate and discuss the optimal management of emergency surgeries in patients with SARS-CoV-2 infection and co-infections. Furthermore, this reprint refers to rare conditions of the digestive system and emphasizes the importance of considering these entities in the differential diagnosis. Awareness of diagnostic imaging hallmarks is crucial to optimize the management of these patients. In this reprint, we discuss the risk of new-onset liver injuries due to COVID-19 in preexisting hepatic conditions, their prognosis, severity and outcome, as well as the immunosuppressant treatments administered for COVID-19 and the possibility of reactivation of the hepatic virus. Moreover, we refer to the drugs used during therapy of hospitalized COVID-19 patients, which have adverse side-effects of drug-induced liver injury—DILI. Finally, this reprint punctuates the importance of vaccination against SARS-CoV-2 in chronic digestive diseases. |
| format | Online |
| id | doab-20.500.12854ir-137769 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2024 |
| publishDateRange | 2024 |
| publishDateSort | 2024 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1377692024-05-14T14:24:37Z The Digestive System in the Era of COVID-19 Paramythiotis, Daniel Karlafti, Eleni COVID-19 digestive symptom dyspepsia immature granulocyte drug-induced liver injury (DILI) liver injury liver dysfunction COVID-19 treatment liver function COVID-19 drugs liver cirrhosis SARS-CoV-2 hepatitis cholangitis chronic liver disease digestive system infection gastrointestinal involvement Clostridium difficile infection colitis surgical intervention mortality abdominal gastrointestinal CT/CTA pancreatitis colitis cholecystitis bleeding vaccination IBD gastrointestinal bleeding esophageal cancer esophagectomy perioperative outcomes post-operative outcomes systematic review meta-analysis small bowel non-Meckelian diverticulitis thema EDItEUR::T Technology, Engineering, Agriculture, Industrial processes::TB Technology: general issues In the last few years, the scientific world has been forced to find ways to manage the SARS-CoV-2 pandemic and its many effects. Even though COVID-19 was first considered a respiratory disease, it is now identified as a systematic disease. It is common for SARS-CoV-2 to also infect the digestive system. This type of infection in patients with COVID-19 has a wide symptom range. The aim of this reprint is to evaluate and discuss the optimal management of emergency surgeries in patients with SARS-CoV-2 infection and co-infections. Furthermore, this reprint refers to rare conditions of the digestive system and emphasizes the importance of considering these entities in the differential diagnosis. Awareness of diagnostic imaging hallmarks is crucial to optimize the management of these patients. In this reprint, we discuss the risk of new-onset liver injuries due to COVID-19 in preexisting hepatic conditions, their prognosis, severity and outcome, as well as the immunosuppressant treatments administered for COVID-19 and the possibility of reactivation of the hepatic virus. Moreover, we refer to the drugs used during therapy of hospitalized COVID-19 patients, which have adverse side-effects of drug-induced liver injury—DILI. Finally, this reprint punctuates the importance of vaccination against SARS-CoV-2 in chronic digestive diseases. 2024-05-14T14:24:30Z 2024-05-14T14:24:30Z 2024 book ONIX_20240514_9783725805716_365 9783725805716 9783725805723 https://directory.doabooks.org/handle/20.500.12854/137769 eng application/octet-stream Attribution-NonCommercial-NoDerivatives 4.0 International https://mdpi.com/books/pdfview/book/9002 https://mdpi.com/books/pdfview/book/9002 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-0572-3 10.3390/books978-3-7258-0572-3 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725805716 9783725805723 140 open access |
| spellingShingle | COVID-19 digestive symptom dyspepsia immature granulocyte drug-induced liver injury (DILI) liver injury liver dysfunction COVID-19 treatment liver function COVID-19 drugs liver cirrhosis SARS-CoV-2 hepatitis cholangitis chronic liver disease digestive system infection gastrointestinal involvement Clostridium difficile infection colitis surgical intervention mortality abdominal gastrointestinal CT/CTA pancreatitis colitis cholecystitis bleeding vaccination IBD gastrointestinal bleeding esophageal cancer esophagectomy perioperative outcomes post-operative outcomes systematic review meta-analysis small bowel non-Meckelian diverticulitis thema EDItEUR::T Technology, Engineering, Agriculture, Industrial processes::TB Technology: general issues The Digestive System in the Era of COVID-19 |
| title | The Digestive System in the Era of COVID-19 |
| title_full | The Digestive System in the Era of COVID-19 |
| title_fullStr | The Digestive System in the Era of COVID-19 |
| title_full_unstemmed | The Digestive System in the Era of COVID-19 |
| title_short | The Digestive System in the Era of COVID-19 |
| title_sort | digestive system in the era of covid 19 |
| topic | COVID-19 digestive symptom dyspepsia immature granulocyte drug-induced liver injury (DILI) liver injury liver dysfunction COVID-19 treatment liver function COVID-19 drugs liver cirrhosis SARS-CoV-2 hepatitis cholangitis chronic liver disease digestive system infection gastrointestinal involvement Clostridium difficile infection colitis surgical intervention mortality abdominal gastrointestinal CT/CTA pancreatitis colitis cholecystitis bleeding vaccination IBD gastrointestinal bleeding esophageal cancer esophagectomy perioperative outcomes post-operative outcomes systematic review meta-analysis small bowel non-Meckelian diverticulitis thema EDItEUR::T Technology, Engineering, Agriculture, Industrial processes::TB Technology: general issues |
| topic_facet | COVID-19 digestive symptom dyspepsia immature granulocyte drug-induced liver injury (DILI) liver injury liver dysfunction COVID-19 treatment liver function COVID-19 drugs liver cirrhosis SARS-CoV-2 hepatitis cholangitis chronic liver disease digestive system infection gastrointestinal involvement Clostridium difficile infection colitis surgical intervention mortality abdominal gastrointestinal CT/CTA pancreatitis colitis cholecystitis bleeding vaccination IBD gastrointestinal bleeding esophageal cancer esophagectomy perioperative outcomes post-operative outcomes systematic review meta-analysis small bowel non-Meckelian diverticulitis thema EDItEUR::T Technology, Engineering, Agriculture, Industrial processes::TB Technology: general issues |
| url | ONIX_20240514_9783725805716_365 |